The New York Times
The Chain of Office of the Dutch city of Leiden is a broad and colorful ceremonial necklace that, draped around the shoulders of Mayor Henri Lenferink, lends a magisterial air to official proceedings in this ancient university town. But whatever gravitas it provided Lenferink as he welcomed a group of researchers to his city, he was quick to undercut it. \u201cI am just a humble historian,\u201d he told the 300 members of the Society for Interdisciplinary Placebo Studies who had gathered in Leiden\u2019s ornate municipal concert hall, \u201cso I don\u2019t know anything about your topic.\u201d He was being a little disingenuous. He knew enough about the topic that these psychologists and neuroscientists and physicians and anthropologists and philosophers had come to his city to talk about \u2014 the placebo effect, the phenomenon whereby suffering people get better from treatments that have no discernible reason to work \u2014 to call it \u201cfake medicine,\u201d and to add that it probably works because \u201cpeople like to be cheated.\u201d He took a beat. \u201cBut in the end, I believe that honesty will prevail.\u201d
Lenferink might not have been so glib had he attended the previous day\u2019s meeting on the other side of town, at which two dozen of the leading lights of placebo science spent a preconference day agonizing over their reputation \u2014 as purveyors of sham medicine who prey on the desperate and, if they are lucky, fool people into feeling better \u2014 and strategizing about how to improve it. It\u2019s an urgent subject for them, and only in part because, like all apostate professionals, they crave mainstream acceptance. More important, they are motivated by a conviction that the placebo is a powerful medical treatment that is ignored by doctors only at their patients\u2019 expense.
And after a quarter-century of hard work, they have abundant evidence to prove it. Give people a sugar pill, they have shown, and those patients \u2014 especially if they have one of the chronic, stress-related conditions that register the strongest placebo effects and if the treatment is delivered by someone in whom they have confidence \u2014 will improve. Tell someone a normal milkshake is a diet beverage, and his gut will respond as if the drink were low fat. Take athletes to the top of the Alps, put them on exercise machines and hook them to an oxygen tank, and they will perform better than when they are breathing room air \u2014 even if room air is all that\u2019s in the tank. Wake a patient from surgery and tell him you\u2019ve done an arthroscopic repair, and his knee gets better even if all you did was knock him out and put a couple of incisions in his skin. Give a drug a fancy name, and it works better than if you don\u2019t.
You don\u2019t even have to deceive the patients. You can hand a patient with irritable bowel syndrome a sugar pill, identify it as such and tell her that sugar pills are known to be effective when used as placebos, and she will get better, especially if you take the time to deliver that message with warmth and close attention. Depression, back pain, chemotherapy-related malaise, migraine, post-traumatic stress disorder: The list of conditions that respond to placebos \u2014 as well as they do to drugs, with some patients \u2014 is long and growing.
But as ubiquitous as the phenomenon is, and as plentiful the studies that demonstrate it, the placebo effect has yet to become part of the doctor\u2019s standard armamentarium \u2014 and not only because it has a reputation as \u201cfake medicine\u201d doled out by the unscrupulous to the credulous. It also has, so far, resisted a full understanding, its mechanisms shrouded in mystery. Without a clear knowledge of how it works, doctors can\u2019t know when to deploy it, or how.
Not that the researchers are without explanations. But most of these have traditionally been psychological in nature, focusing on mechanisms like expectancy \u2014 the set of beliefs that a person brings into treatment \u2014 and the kind of conditioning that Ivan Pavlov first described more than a century ago. These theories, which posit that the mind acts upon the body to bring about physical responses, tend to strike doctors and researchers steeped in the scientific tradition as insufficiently scientific to lend credibility to the placebo effect. \u201cWhat makes our research believable to doctors?\u201d asks Ted Kaptchuk, head of Harvard Medical School\u2019s Program in Placebo Studies and the Therapeutic Encounter. \u201cIt\u2019s the molecules. They love that stuff.\u201d As of now, there are no molecules for conditioning or expectancy \u2014 or, indeed, for Kaptchuk\u2019s own pet theory, which holds that the placebo effect is a result of the complex conscious and nonconscious processes embedded in the practitioner-patient relationship \u2014 and without them, placebo researchers are hard-pressed to gain purchase in mainstream medicine.
But as many of the talks at the conference indicated, this might be about to change. Aided by functional magnetic resonance imaging (f.M.R.I.) and other precise surveillance techniques, Kaptchuk and his c...